Cytokines Increase Neonatal Cardiac Myocyte Calcium Concentrations: The Involvement of Nitric Oxide and Cyclic Nucleotides
- 1 June 1999
- journal article
- research article
- Published by Mary Ann Liebert Inc in Journal of Interferon & Cytokine Research
- Vol. 19 (6) , 645-653
- https://doi.org/10.1089/107999099313794
Abstract
Neonatal rat cardiac myocytes were treated with cytokines, with or without the nitric oxide synthase (NOS) inhibitors N-monomethyl-L-arginine (LNMMA) and N-nitro-L-arginine methyl ester (LNAME), and systolic and diastolic calcium levels were measured by fluorescence spectrophotometry and confocal microscopy. Time-dependent changes following interferon-gamma (IFN-gamma) treatment revealed a continuing increase in intracellular calcium, which was reduced with LNMMA, but not with LNAME. Increases in calcium also occurred with interleukin-1beta (IL-1beta) and tumor necrosis factor-alpha (TNF-alpha), but not to the extent seen with IFN-gamma. Increased cyclic guanosine monophosphate (cGMP) was involved in the results described with short-term (2 hr) TNF-alpha and long-term (18 hr) IFN-gamma treatments. Short-term exposure to IFN-gamma produced an increase in cyclic adenosine monophosphate (cAMP) and also an initial increase in the myocyte-bearing rate, with calcium levels either (i) subsequently returning to control levels while maintaining a fast beating rate or (ii), retaining a high systolic calcium level, but beating at control rates. Treatment with both IL-1beta and IFN-gamma stabilized the beating rate of the cells on some occasions. Shortening of myocytes increased with isoproterenol and following treatment with IFN-gamma, while isoproterenol stimulation of IFN-gamma-treated cells revealed increased contractile activity after short, but not long, treatment. LNMMA, but not reduced the increased contractile response with short-term IFN-gamma treatment. Our findings suggest that TNF-alpha acts via a cGMP-dependent pathway, whereas the actions of IFN-gamma involve adenylate cyclase, and possibly a NO-forming mechanism and cGMP pathway as well. It is also apparent that the two NO inhibitors function via different mechanisms or that LNMMA has a direct effect on the calcium-signaling pathway.Keywords
This publication has 19 references indexed in Scilit:
- DIFFERENTIAL REGULATION OF INTERLEUKIN 4 AND INTERLEUKIN 13 PRODUCITON BY INTERFERON αCytokine, 1998
- Adenosine Inhibits Lipopolysaccharide-Induced Cardiac Expression of Tumor Necrosis Factor-αCirculation Research, 1998
- Elevated plasma levels of tumor necrosis factor in chronic heart failure with cachexiaInternational Journal of Cardiology, 1997
- Mechanisms of Interleukin-1β Regulation of Nitric Oxide Synthase in Cardiac MyocytesHypertension, 1996
- Characterization of inducible nitric oxide synthase expression in endotoxernic rat cardiac myocytes in vivo and following cytokine exposure in vitroJournal of Molecular and Cellular Cardiology, 1995
- Effects of immunosuppressive therapy on expression of inducible nitric oxide synthase (iNOS) during cardiac allograft rejectionInternational Journal of Cardiology, 1995
- The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor beta.Journal of Clinical Investigation, 1995
- Chronotropic Effects of Cytokines and the Nitric Oxide Synthase Inhibitor, L-NMMA, on Cardiac MyocytesBiochemical and Biophysical Research Communications, 1994
- Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium.Journal of Clinical Investigation, 1993
- Relationship between calcium loading and impaired energy metabolism during Na+, K+ pump inhibition and metabolic inhibition in cultured neonatal rat cardiac myocytes.Journal of Clinical Investigation, 1989